In today’s podcast, Dr. Lewis Blevins discusses relacorilant, a drug currently in development by Corcept Therapeutics for the treatment of hypercortisolism. Clinical trials to date have shown encouraging results, with improvements in blood pressure, glucose control, weight, and body composition. Corcept Therapeutics specializes in developing drugs that modulate the glucocorticoid receptor.
Stay tuned! Coming later this week the next podcast on the prevalence of hypercortisolism in people with type 2 diabetes.
Music Composed and Produced by, MusicWorksFoundry(TM) (ASCAP). All Rights Reserved
© 2025, J D Faccinetti. All rights reserved.